Anastasios Dimou

1.5k total citations
67 papers, 800 citations indexed

About

Anastasios Dimou is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Anastasios Dimou has authored 67 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 34 papers in Pulmonary and Respiratory Medicine and 16 papers in Molecular Biology. Recurrent topics in Anastasios Dimou's work include Lung Cancer Treatments and Mutations (26 papers), Lung Cancer Research Studies (15 papers) and Lung Cancer Diagnosis and Treatment (12 papers). Anastasios Dimou is often cited by papers focused on Lung Cancer Treatments and Mutations (26 papers), Lung Cancer Research Studies (15 papers) and Lung Cancer Diagnosis and Treatment (12 papers). Anastasios Dimou collaborates with scholars based in United States, Greece and Japan. Anastasios Dimou's co-authors include Muhammad Wasif Saif, Kostas Syrigos, Konstantinos N. Syrigos, Young Kwang Chae, Konstantinos Syrigos, David L. Rimm, William Tester, Valsamo Anagnostou, Apostolos Perelas and Adam K. Rowden and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Anastasios Dimou

59 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anastasios Dimou United States 16 481 311 201 115 72 67 800
Seyoung Seo South Korea 15 369 0.8× 294 0.9× 217 1.1× 112 1.0× 68 0.9× 46 676
Arsela Prelaj Italy 18 677 1.4× 521 1.7× 169 0.8× 152 1.3× 52 0.7× 82 1.0k
Thomas J. Semrad United States 15 395 0.8× 237 0.8× 257 1.3× 162 1.4× 99 1.4× 51 890
Marcella Occelli Italy 15 353 0.7× 176 0.6× 141 0.7× 101 0.9× 46 0.6× 29 691
Hazem El‐Osta United States 16 434 0.9× 234 0.8× 262 1.3× 109 0.9× 117 1.6× 35 893
Claudia Proto Italy 18 780 1.6× 531 1.7× 213 1.1× 150 1.3× 51 0.7× 93 1.2k
Alyssa Klein United States 11 331 0.7× 372 1.2× 180 0.9× 106 0.9× 66 0.9× 28 754
Jenny Furlanetto Germany 16 553 1.1× 215 0.7× 122 0.6× 278 2.4× 61 0.8× 47 797
Jakob M. Riedl Austria 15 561 1.2× 262 0.8× 126 0.6× 157 1.4× 90 1.3× 44 833

Countries citing papers authored by Anastasios Dimou

Since Specialization
Citations

This map shows the geographic impact of Anastasios Dimou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anastasios Dimou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anastasios Dimou more than expected).

Fields of papers citing papers by Anastasios Dimou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anastasios Dimou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anastasios Dimou. The network helps show where Anastasios Dimou may publish in the future.

Co-authorship network of co-authors of Anastasios Dimou

This figure shows the co-authorship network connecting the top 25 collaborators of Anastasios Dimou. A scholar is included among the top collaborators of Anastasios Dimou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anastasios Dimou. Anastasios Dimou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sridhar, Arthi, Anastasios Dimou, Kaushal Parikh, et al.. (2025). Combination of Lurbinectedin and Osimertinib for Treatment of EGFR-Mutated Transformed SCLC: A Brief Report. JTO Clinical and Research Reports. 6(6). 100807–100807. 1 indexed citations
2.
Yao, Yuan, Vera J. Suman, Allan B. Dietz, et al.. (2025). Phase I study of pembrolizumab in combination with ibrutinib for the treatment of unresectable or metastatic melanoma. Frontiers in Immunology. 16. 1491448–1491448.
3.
Hazim, Antonious, An Xiao, Aditi P. Singh, et al.. (2024). EP.07C.16 Real-World Outcomes of Patients with Resectable Early-Stage Non-Small Cell Lung Cancer Treated with Neoadjuvant Chemoimmunotherapy. Journal of Thoracic Oncology. 19(10). S546–S547.
4.
5.
Le, Anh T., et al.. (2023). Intrinsic resistance to ROS1 inhibition in a patient with CD74‐ROS1 mediated by AXL overexpression. Thoracic Cancer. 14(33). 3259–3265. 2 indexed citations
6.
Smith, Katherine E., Sarah M. Jenkins, Anastasios Dimou, et al.. (2023). Immune infiltrates in metastatic uveal melanoma liver metastases and associations with clinical outcomes.. Journal of Clinical Oncology. 41(16_suppl). 9538–9538. 1 indexed citations
7.
Desai, Aakash, Sagar Rakshit, Radhika Bansal, et al.. (2023). Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report. Cancer Treatment and Research Communications. 36. 100743–100743. 15 indexed citations
8.
Dimou, Anastasios. (2023). Time to Think about HLA-Based Diagnostics in Lung Cancer?. Clinical Cancer Research. 29(23). 4706–4708.
9.
Smith, Katherine E., Adam J. Weisbrod, Carrie Strand, et al.. (2023). Abstract CT207: Phase I trial of vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 (VSV-IFNb-TYRP1) in metastatic ocular melanoma. Cancer Research. 83(8_Supplement). CT207–CT207. 1 indexed citations
10.
Desai, Aakash, Jacob J. Orme, Saurabh Zanwar, et al.. (2023). Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer. Clinical Lung Cancer. 24(8). 689–695.e1. 15 indexed citations
11.
Dimou, Anastasios, et al.. (2020). HLA Class I Binding of Mutant EGFR Peptides in NSCLC Is Associated With Improved Survival. Journal of Thoracic Oncology. 16(1). 104–112. 9 indexed citations
12.
Dimou, Anastasios, et al.. (2020). Granulomatosis with polyangiitis in a patient treated with dabrafenib and trametinib for BRAF V600E positive lung adenocarcinoma. BMC Cancer. 20(1). 177–177. 4 indexed citations
13.
Patil, Tejas, Jose M. Pacheco, Anastasios Dimou, et al.. (2020). Cecal Volvulus as a Rare Complication of Osimertinib Dosed at 160 mg in Patients With EGFR-Mutant Non-small Cell Lung Cancer. Frontiers in Oncology. 10. 510–510. 1 indexed citations
14.
Dimou, Anastasios, Terry L. Ng, A. Chalmers, et al.. (2018). OA12.06 Mutational Landscape of BRAF V600E Positive Lung Cancer Patients Following BRAF Directed Therapy Failure. Journal of Thoracic Oncology. 13(10). S349–S349.
15.
Dimou, Anastasios, Carol A. Sherman, & John Wrangle. (2016). Imaging in Advanced Non–Small Cell Lung Cancer. Journal of Thoracic Imaging. 31(4). 238–242. 3 indexed citations
16.
Perelas, Apostolos, et al.. (2015). Incidental Findings on Computed Tomography Angiography in Patients Evaluated for Pulmonary Embolism. Annals of the American Thoracic Society. 12(5). 689–695. 23 indexed citations
17.
Chae, Young Kwang, Anastasios Dimou, Sherry Pierce, Hagop M. Kantarjian, & Michael Andreeff. (2014). The effect of calcium channel blockers on the outcome of acute myeloid leukemia. Leukemia & lymphoma. 55(12). 2822–2829. 15 indexed citations
18.
Dimou, Anastasios, Seema Agarwal, Valsamo Anagnostou, et al.. (2011). Standardization of Epidermal Growth Factor Receptor (EGFR) Measurement by Quantitative Immunofluorescence and Impact on Antibody-Based Mutation Detection in Non–Small Cell Lung Cancer. American Journal Of Pathology. 179(2). 580–589. 19 indexed citations
19.
Anagnostou, Valsamo, Anastasios Dimou, Taxiarchis Botsis, et al.. (2011). Molecular classification of nonsmall cell lung cancer using a 4‐protein quantitative assay. Cancer. 118(6). 1607–1618. 24 indexed citations
20.
Dimou, Anastasios, Kostas Syrigos, & Muhammad Wasif Saif. (2009). Disparities in colorectal cancer in African-Americans vs Whites: Before and after diagnosis. World Journal of Gastroenterology. 15(30). 3734–3734. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seyoung Seo Breakdown of academic impact, for papers by Arsela Prelaj Breakdown of academic impact, for papers by Thomas J. Semrad Breakdown of academic impact, for papers by Marcella Occelli Breakdown of academic impact, for papers by Hazem El‐Osta Breakdown of academic impact, for papers by Claudia Proto Breakdown of academic impact, for papers by Alyssa Klein Breakdown of academic impact, for papers by Jenny Furlanetto Breakdown of academic impact, for papers by Jakob M. Riedl
Rankless by CCL
2026